$BSLK
Bolt Projects Holdings, Inc. Stock $bslk

$bslk Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023024827 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$428.9K	$1.344M	$1.023M
YoY Change	-23.06%	31.4%
Operating Profit		-$1.344M	-$1.023M
YoY Change		31.4%
Interest Expense	$3.149M	$11.14M	$6.773M
YoY Change	1864.6%	64.45%
% of Operating Profit
Other Income/Expense, Net	$130.0K	$11.95M	$6.292M
YoY Change		89.94%
Pretax Income	$2.850M	$10.61M	$5.269M
YoY Change	-817.48%	101.3%
Income Tax	$498.2K	$759.6K
% Of Pretax Income	17.48%	7.16%
Net Earnings	$2.352M	$9.847M	$5.269M
YoY Change	-692.05%	86.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.07	$0.27	$179.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$348.8K	$348.8K	$366.6K
YoY Change	-4.87%	-4.87%
Cash & Equivalents	$348.7K
Short-Term Investments
Other Short-Term Assets	$72.30K	$72.30K	$352.2K
YoY Change	-79.47%	-79.47%
Inventory
Prepaid Expenses	$72.30K
Receivables
Other Receivables
Total Short-Term Assets	$421.0K	$421.1K	$718.8K
YoY Change	-41.42%	-41.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$290.6M	$290.6M	$287.5M
YoY Change	1.09%	1.09%
Other Assets
YoY Change
Total Long-Term Assets	$290.6M	$290.6M	$287.5M
YoY Change	1.09%	1.09%
TOTAL ASSETS
Total Short-Term Assets	$421.0K	$421.1K	$718.8K
Total Long-Term Assets	$290.6M	$290.6M	$287.5M
Total Assets	$291.1M	$291.1M	$288.2M
YoY Change	0.98%	0.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$249.5K	$249.5K	$322.1K
YoY Change	-16.84%	-22.54%
Accrued Expenses	$249.5K		$322.1K
YoY Change	-22.54%
Deferred Revenue
YoY Change
Short-Term Debt	$88.85K	$88.85K	$141.4K
YoY Change	-37.15%	-37.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$587.0K	$587.0K	$463.4K
YoY Change	26.66%	26.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.21M	$10.21M	$17.35M
YoY Change	-41.15%	-41.15%
Total Long-Term Liabilities	$10.21M	$10.21M	$17.35M
YoY Change	-41.15%	-41.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$587.0K	$587.0K	$463.4K
Total Long-Term Liabilities	$10.21M	$10.21M	$17.35M
Total Liabilities	$10.80M	$10.80M	$17.81M
YoY Change	-39.39%	-39.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.09M
YoY Change	-40.93%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.09M	$280.3M	$270.4M
YoY Change
Total Liabilities & Shareholders Equity	$291.1M	$291.1M	$288.2M
YoY Change	0.98%	0.98%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	$2.352M	$9.847M	$5.269M
YoY Change	-692.05%	86.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$736.4K	-$1.647M	-$1.053M
YoY Change	120.52%	56.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$871.0K	$871.0K	-$287.5M
YoY Change		-100.3%
Cash From Investing Activities	$871.0K	$871.0K	-$287.5M
YoY Change		-100.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-141.4K	$758.6K	288.9M
YoY Change	2727.4%	-99.74%
NET CHANGE
Cash From Operating Activities	-736.4K	-$1.647M	-1.053M
Cash From Investing Activities	871.0K	$871.0K	-287.5M
Cash From Financing Activities	-141.4K	$758.6K	288.9M
Net Change In Cash	-6.800K	-$17.86K	366.6K
YoY Change	-97.99%	-104.87%
FREE CASH FLOW
Cash From Operating Activities	-$736.4K	-$1.647M	-$1.053M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 E. 53rd Street
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40223
CY2022	dei	Entity Registrant Name EntityRegistrantName	GOLDEN ARROW MERGER CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-1256660
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	13th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2022	dei	City Area Code CityAreaCode	(212)
CY2022	dei	Local Phone Number LocalPhoneNumber	430-2214
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	GAMC
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	280600000	usd
CY2022	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348749	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	366612	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	72297	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	352184	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	421046	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	718796	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	290646467	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	287517003	usd
CY2022Q4	us-gaap	Assets Assets	291067513	usd
CY2021Q4	us-gaap	Assets Assets	288235799	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	249489	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	322074	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	141367	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	88850	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	248647	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	586986	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	463441	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	10062500	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	10062500	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	145833	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	7284375	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10795319	usd
CY2021Q4	us-gaap	Liabilities Liabilities	17810316	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	290357770	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	287500000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	gamc	Common Stock Value1 CommonStockValue1	719	usd
CY2021Q4	gamc	Common Stock Value1 CommonStockValue1	719	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10086295	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17075236	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10085576	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-17074517	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	291067513	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	288235799	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1343799	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1022676	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1343799	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1022676	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-481824	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7138542	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6756458	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	811150	usd
CY2022	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	4000465	usd
CY2021	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	17003	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11950157	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6291637	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10606358	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5268961	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	759647	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9846711	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5268961	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	25023478	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2655000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5268961	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-17074517	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2857770	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9846711	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10085576	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9846711	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5268961	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	811150	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7138542	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6756458	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	481824	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000465	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	17003	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-279888	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	352184	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-72585	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	322074	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	248647	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1647496	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1052786	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	287500000	usd
CY2022	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	871000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	871000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-287500000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	281750000	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7500000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	141367	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	141367	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10123	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	900000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	486846	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	758633	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	288919398	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17863	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	366612	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	366612	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	348749	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	366612	usd
CY2021	gamc	Offering Costs Paid Through Promissory Note OfferingCostsPaidThroughPromissoryNote	10123	usd
CY2021	gamc	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	10062500	usd
CY2022Q4	gamc	Transaction Costs TransactionCosts	16309469	usd
CY2022	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	5750000	usd
CY2022	gamc	Deferred Underwriting Fees DeferredUnderwritingFees	10062500	usd
CY2022Q4	gamc	Other Offering Costs OtherOfferingCosts	496969	usd
CY2022	gamc	Percentage Held In Trust Account PercentageHeldInTrustAccount	0.80	pure
CY2022	gamc	Public Share Price Per Share PublicSharePricePerShare	10
CY2022	gamc	Aggregate Of Shares Sold Percentage AggregateOfSharesSoldPercentage	0.15	pure
CY2022	gamc	Redemption Of Public Shares Percentage RedemptionOfPublicSharesPercentage	1	pure
CY2022	gamc	Net Interest To Pay Dissolution Expenses NetInterestToPayDissolutionExpenses	100000	usd
CY2022Q4	gamc	Initial Public Offering Price Per Unit InitialPublicOfferingPricePerUnit	10
CY2022	gamc	Public Per Share PublicPerShare	10
CY2022Q4	gamc	Working Captial Deficit WorkingCaptialDeficit	348749	usd
CY2022Q4	us-gaap	Capital Capital	165940	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	871000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i> </i></b></p>
CY2022	gamc	Consulting Fees ConsultingFees	210000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	287500000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	9195833	usd
CY2021	gamc	Class A Common Stock Issuance Costs ClassACommonStockIssuanceCosts	-15827645	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	25023478	usd
CY2021Q4	gamc	Class A Common Stock Subject To Possible Redemption ClassACommonStockSubjectToPossibleRedemption	287500000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	2857770	usd
CY2022Q4	gamc	Class A Common Stock Subject To Possible Redemption ClassACommonStockSubjectToPossibleRedemption	290357770	usd
CY2022	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	15827645	usd
CY2022	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	481824	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	759647	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i> </i></p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	gamc	Public Offering PublicOffering	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 3. PUBLIC OFFERING</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). On May 6, 2021, the Company sold 3,750,000 Additional Units at $10.00 per Additional Unit. The Additional Units were identical to the Units sold pursuant to the Initial Public Offering.</p>
CY2022	gamc	Public Offering Description PublicOfferingDescription	Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3750000	shares
CY2021Q2	gamc	Sale Of Stock Price Per Share1 SaleOfStockPricePerShare1	10
CY2021Q1	us-gaap	Sponsor Fees SponsorFees	25000	usd
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	7187500	shares
CY2021Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	937500	shares
CY2021Q1	us-gaap	Investment Company Contributed Capital To Committed Capital Ratio InvestmentCompanyContributedCapitalToCommittedCapitalRatio	0.20	pure
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	12
CY2021Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	200000	usd
CY2022	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	usd
CY2021	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	141367	usd
CY2021Q4	gamc	Working Capital Loans WorkingCapitalLoans	1500000	usd
CY2022Q4	gamc	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
CY2021Q4	gamc	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
CY2022Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	500000	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.5
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	400000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	900000	usd
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2022	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	88850	usd
CY2022	us-gaap	Results Of Operations Sales Or Transfers To Entitys Other Operations ResultsOfOperationsSalesOrTransfersToEntitysOtherOperations	811150	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign	0.01	pure
CY2022Q3	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	0.01	pure
CY2022Q4	gamc	Deferred Underwriting Fee Price Per Unit DeferredUnderwritingFeePricePerUnit	0.35
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10062500	usd
CY2022Q4	gamc	Economic Share Interest EconomicShareInterest	100000	shares
CY2022Q4	gamc	Founders Shares FoundersShares	100000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.20	pure
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9583333	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9583333	shares
CY2022	gamc	Warrant Expire Years WarrantExpireYears	P5Y
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38440	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	412939	usd
CY2021Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	172751	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	412939	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	211191	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	412939	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	211191	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	759647	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-201748	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-211191	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	201748	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	211191	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	759647	usd
CY2022	gamc	Net Operating Loss Carryovers NetOperatingLossCarryovers	0	usd
CY2021	gamc	Net Operating Loss Carryovers NetOperatingLossCarryovers	183047	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	201748	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	211191	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	-0.141	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	-0.269	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.019	pure
CY2022	gamc	Change In Fair Value Of Convertible Promissory Note Related Partyin Dollars ChangeInFairValueOfConvertiblePromissoryNoteRelatedPartyinDollars	-0.017	pure
CY2021	gamc	Change In Fair Value Of Convertible Promissory Note Related Partyin Dollars ChangeInFairValueOfConvertiblePromissoryNoteRelatedPartyinDollars	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.019	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.04	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.071	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	290646467	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	871000	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	287517003	usd
CY2022Q4	us-gaap	Share Price SharePrice	10.02
CY2021Q4	us-gaap	Share Price SharePrice	9.68
CY2022Q4	us-gaap	Derivative Price Risk Option Strike Price DerivativePriceRiskOptionStrikePrice	11.5
CY2021Q4	us-gaap	Derivative Price Risk Option Strike Price DerivativePriceRiskOptionStrikePrice	11.5
CY2022	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2023-09-17
CY2021	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2026-08-03
CY2022	gamc	Volatility Volatility	0.07	pure
CY2021	gamc	Volatility Volatility	0.113	pure
CY2022	gamc	Riskfree Rate RiskfreeRate	0.0469	pure
CY2021	gamc	Riskfree Rate RiskfreeRate	0.012	pure
CY2022	gamc	Dividend Yield DividendYield	0	pure
CY2021	gamc	Dividend Yield DividendYield	0	pure
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	7954167	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	9.7
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	9.8
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	9.81
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	10.02
CY2022Q1	gamc	Strike Price StrikePrice	11.5
CY2022Q3	gamc	Strike Price StrikePrice	11.5
CY2022Q3	gamc	Strike Price StrikePrice	11.5
CY2022	gamc	Strike Price StrikePrice	11.5
CY2022Q1	gamc	Expiration Date Of Warrants ExpirationDateOfWarrants	2027-09-19
CY2022Q3	gamc	Expiration Date Of Warrants ExpirationDateOfWarrants	2024-06-17
CY2022Q3	gamc	Expiration Date Of Warrants ExpirationDateOfWarrants	2024-06-17
CY2022	gamc	Expiration Date Of Warrants ExpirationDateOfWarrants	2023-09-17
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.084	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.072	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.066	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.07	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0188	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0334	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0348	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0469	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	270869315	usd
CY2022	gamc	Trust Account TrustAccount	21349573	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent		usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	gamc	Offering Costs Paid Through Promissory Note OfferingCostsPaidThroughPromissoryNote		usd
CY2022	gamc	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2021Q2	gamc	Shares Subject To Forfeiture SharesSubjectToForfeiture		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001841125

Files In Submission

Name	View Source	Status
0001213900-23-024827-index-headers.html	Edgar Link	pending
0001213900-23-024827-index.html	Edgar Link	pending
0001213900-23-024827.txt	Edgar Link	pending
0001213900-23-024827-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_goldenarrow.htm	Edgar Link	pending
f10k2022ex32-1_goldenarrow.htm	Edgar Link	pending
f10k2022_goldenarrow.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gamc-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gamc-20221231_lab.xml	Edgar Link	unprocessable
gamc-20221231_def.xml	Edgar Link	unprocessable
f10k2022_goldenarrow_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gamc-20221231_cal.xml	Edgar Link	unprocessable
gamc-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BSLK
Bolt Projects Holdings, Inc. Stock $bslk

2022 Q4 Form 10-K Financial Statement

#000121390023024827 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSLK Bolt Projects Holdings, Inc. Stock $bslk

2022 Q4 Form 10-K Financial Statement

#000121390023024827 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSLK
Bolt Projects Holdings, Inc. Stock $bslk